FDA Inspection 1019795 — SmithKline Beecham Pharma GmbH & co. KG
The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on June 27, 2017 in Dresden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 27, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Dresden (Germany)